Clinical Trials Sponsored by Jiangsu Simcere Pharmaceutical R&D Co. Ltd

Total 84 results

Jiangsu Simcere Biologics Co., Ltd

Recruiting

A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors

Advanced Solid Tumor | Cutaneous T Cell Lymphoma

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Recruiting

Safety and Pharmacokinetics of SIM0417 Combined With Ritonavir in Healthy Elderly Subjects

Elder

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Not yet recruiting

Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With Ritonavir

Renal Impairment | Hepatic Impairment

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Not yet recruiting

Evaluation of SSD8432 and Ritonavir in Adult Subjects With COVID-19 Clinical Study

COVID-19
Jiangsu Simcere Pharmaceutical Co., Ltd.

Recruiting

Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer

Breast Cancer

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

To Evaluate SSD8432/ Ritonavir in Adults With COVID-19

COVID-19 Patients

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke

Acute Ischemic Stroke

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Phase I Clinical Study of Metatinib Tromethamine Tablet

Advanced or Metastatic Solid Tumors

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC

Non-small Cell Lung Cancer

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid Tumors

Advanced Solid Tumors | Metastatic Solid Tumors

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration.

Lung Cancer

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China

Influenza A Virus Infection | Influenza B Virus Infection

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Not yet recruiting

Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of Escalating Doses of SIM0348 as a Single Agent in Advanced Solid Tumors

Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.

Not yet recruiting

To Evaluate SSD8432/Ritonavir in Adults With COVID-19

COVID-19
Jiangsu Simcere Pharmaceutical Co., Ltd.

Recruiting

A Phase I Clinical Study of SSD8432 in Healthy Adult Subjects

Healthy Participants

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Not yet recruiting

PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy

Advanced or Metastatic NSCLC

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Recruiting

An Open Label, Multi-center, Phase I Clinical Study to Evaluate the Safety, Effectiveness and Pharmacokinetic Characteristics of SIM1803-1A in Patients With Locally Advanced/Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion Mutations.

Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy Subjects

Healthy Volunteer

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

The Tolerability, Safety, and PK Characteristics of SIM1910-09 in Healthy Chinese Volunteers

Acute Ischemic Stroke | Cerebral Edema

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Study to Investigate the Mass Balance and Biotransformation of SIM0417 in Healthy Adult Chinese Male Participants

Healthy Male Volunteers

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Compound Edaravone Injection for Acute Ischemic Stroke

Acute Ischemic Stroke

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI

Rheumatoid Arthritis

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients

Non-Small Cell Lung Cancer

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Recruiting

To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subjects

Healthy Volunteers

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Recruiting

A Study of Daridorexant in Chinese Patients With Insomnia Disorder

Insomnia Disorder

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Recruiting

A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma

Advanced Solid Tumor | Cutaneous T-cell Lymphoma (CTCL)

United States
Jiangsu Simcere Pharmaceutical Co., Ltd.

Recruiting

A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant Tumors

Solid Tumor | Non Hodgkin Lymphoma

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions

Malignant Pleural Effusion

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.

Primary Sjögren Syndrome

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Terminated

A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19

COVID-19

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Drug-Drug Interaction Study of Itraconazole, Rifampicin and Midazolam With SIM0417/Ritonavir in Healthy Participants

Healthy Volunteers

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

A Study of Iguratimod in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors

NSCLC | Solid Tumor

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer.

Ovarian Cancer

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma

Squamous Cell Carcinoma

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

Study of Metatinib Tromethamine Tablet

Advanced or Metastatic Gastric Cancer | Advanced or Metastatic CRC | Advanced or Metastatic Liver Cancer | Advanced or Metastatic Non Squamous NSCLC

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma

Multiple Myeloma

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

Study of Endostar Subcutaneous Injection in NSCLC

NSCLC

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy

Cancer

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

Fluorouracil Implants Used for Intraperitoneal Chemotherapy During Operation for Treatment of Phase III Gastric Cancer.

DSF

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites

Malignant Ascites | Malignant Pleural Effusion

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of Simotinib Hydrochloride in Healthy Subjects

Healthy

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypertension

Essential Hypertension

China
Jiangsu Simcere Pharmaceutical Co., Ltd.
Shanghai Xianxiang Medical Technology Co., Ltd.; Simcere Zaiming

Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants With Advanced Solid Tumors

Locally Advanced Unresectable or Metastatic Solid Tumor

United States, China

3

Subscribe